BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yan L, Gao S, Shui S, Liu S, Qu H, Liu C, Zheng L. Small interfering RNA-loaded chitosan hydrochloride/carboxymethyl chitosan nanoparticles for ultrasound-triggered release to hamper colorectal cancer growth in vitro. International Journal of Biological Macromolecules 2020;162:1303-10. [DOI: 10.1016/j.ijbiomac.2020.06.246] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
Number Citing Articles
1 Jie Y, Chen F. High-internal-phase emulsions stabilized solely by chitosan hydrochloride: Fabrication and effect of pH on stabilization mechanism. Food Hydrocolloids 2023;135:108194. [DOI: 10.1016/j.foodhyd.2022.108194] [Reference Citation Analysis]
2 Choukaife H, Seyam S, Alallam B, Doolaanea AA, Alfatama M. Current Advances in Chitosan Nanoparticles Based Oral Drug Delivery for Colorectal Cancer Treatment. Int J Nanomedicine 2022;17:3933-66. [PMID: 36105620 DOI: 10.2147/IJN.S375229] [Reference Citation Analysis]
3 Guo Y, Wang M, Zou Y, Jin L, Zhao Z, Liu Q, Wang S, Li J. Mechanisms of chemotherapeutic resistance and the application of targeted nanoparticles for enhanced chemotherapy in colorectal cancer. J Nanobiotechnology 2022;20:371. [PMID: 35953863 DOI: 10.1186/s12951-022-01586-4] [Reference Citation Analysis]
4 Zheng W, Zhang H, Wang J, Wang J, Yan L, Liu C, Zheng L. Pickering emulsion hydrogel based on alginate-gellan gum with carboxymethyl chitosan as a pH-responsive controlled release delivery system. Int J Biol Macromol 2022:S0141-8130(22)01663-4. [PMID: 35914551 DOI: 10.1016/j.ijbiomac.2022.07.223] [Reference Citation Analysis]
5 Liu S, Yang Q, Zhang J, Yang M, Wang Y, Sun T, Ma C, Abd El-Aty AM. Enhanced stability of stilbene-glycoside-loaded nanoparticles coated with carboxymethyl chitosan and chitosan hydrochloride. Food Chem 2022;372:131343. [PMID: 34656910 DOI: 10.1016/j.foodchem.2021.131343] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
6 Kara G, Calin GA, Ozpolat B. RNAi-based therapeutics and tumor targeted delivery in cancer. Adv Drug Deliv Rev 2022;182:114113. [PMID: 35063535 DOI: 10.1016/j.addr.2022.114113] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 19.0] [Reference Citation Analysis]
7 Yadav S, Jain VK, Jain K. Marine Biopolymers for Gene Delivery. Marine Biomaterials 2022. [DOI: 10.1007/978-981-16-5374-2_5] [Reference Citation Analysis]
8 Liu G, Yang L, Chen G, Xu F, Yang F, Yu H, Li L, Dong X, Han J, Cao C, Qi J, Su J, Xu X, Li X, Li B. A Review on Drug Delivery System for Tumor Therapy. Front Pharmacol 2021;12:735446. [PMID: 34675807 DOI: 10.3389/fphar.2021.735446] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
9 Mikušová V, Mikuš P. Advances in Chitosan-Based Nanoparticles for Drug Delivery. Int J Mol Sci 2021;22:9652. [PMID: 34502560 DOI: 10.3390/ijms22179652] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 15.0] [Reference Citation Analysis]
10 Rinoldi C, Zargarian SS, Nakielski P, Li X, Liguori A, Petronella F, Presutti D, Wang Q, Costantini M, De Sio L, Gualandi C, Ding B, Pierini F. Nanotechnology-Assisted RNA Delivery: From Nucleic Acid Therapeutics to COVID-19 Vaccines. Small Methods 2021;:2100402. [PMID: 34514087 DOI: 10.1002/smtd.202100402] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 8.5] [Reference Citation Analysis]
11 Bhaskaran NA, Kumar L. Treating colon cancers with a non-conventional yet strategic approach: An overview of various nanoparticulate systems. J Control Release 2021;336:16-39. [PMID: 34118336 DOI: 10.1016/j.jconrel.2021.06.008] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
12 Ginghină O, Hudiță A, Zaharia C, Tsatsakis A, Mezhuev Y, Costache M, Gălățeanu B. Current Landscape in Organic Nanosized Materials Advances for Improved Management of Colorectal Cancer Patients. Materials (Basel) 2021;14:2440. [PMID: 34066710 DOI: 10.3390/ma14092440] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
13 Jaiswal S, Dutta P, Kumar S, Chawla R. Chitosan modified by organo-functionalities as an efficient nanoplatform for anti-cancer drug delivery process. Journal of Drug Delivery Science and Technology 2021;62:102407. [DOI: 10.1016/j.jddst.2021.102407] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
14 Yan L, Wei L, Zheng W, Liu S, Yin L, Liu C, Zheng L. Oral Delivery of Chitosan Derivative-Based Nanoparticles Encapsulating Quercetin to Attenuate Intestinal Injury and Regulate Gut Microbiota Dysbiosis in Mucositis Treatment. ACS Food Sci Technol 2021;1:399-409. [DOI: 10.1021/acsfoodscitech.0c00121] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
15 Ashrafizadeh M, Delfi M, Hashemi F, Zabolian A, Saleki H, Bagherian M, Azami N, Farahani MV, Sharifzadeh SO, Hamzehlou S, Hushmandi K, Makvandi P, Zarrabi A, Hamblin MR, Varma RS. Biomedical application of chitosan-based nanoscale delivery systems: Potential usefulness in siRNA delivery for cancer therapy. Carbohydr Polym 2021;260:117809. [PMID: 33712155 DOI: 10.1016/j.carbpol.2021.117809] [Cited by in Crossref: 58] [Cited by in F6Publishing: 61] [Article Influence: 29.0] [Reference Citation Analysis]